Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

MabThera/Rituxan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. MabThera/Rituxan was produced by Roche.

Roche reports continued growth in Q3, despite biosimilar competition

Roche reports continued growth in Q3, despite biosimilar competition

The uptake of new medicines has offset the decreased sales of Herceptin and Rituxan, which have lost their respective patents and so have faced competition from generic sales. ... In Europe, sales were down 1% thanks to the competition from biosimilars

Roche’s MabThera beats incumbent drug in pemphigus vulgaris phase 3

Roche’s MabThera beats incumbent drug in pemphigus vulgaris phase 3 MabThera, which is sold in some markets as Rituxan, won approval in the US in pemphigus vulgaris in June 2018 and was cleared for use in the European Union the following ... Mabthera/Rituxan may be a superior treatment option to mycophenolate

Roche wins FDA breakthrough for Gazyva in lupus nephritis

Roche wins FDA breakthrough for Gazyva in lupus nephritis Roche has been counting on a new class of medicines to help offset the  biosimilar onslaught on its ageing cancer blockbusters, including Herceptin and MabThera/Rituxan.

Genentech agrees trade secret theft settlement with Taiwan’s JHL

Genentech agrees trade secret theft settlement with Taiwan’s JHL News of the spat emerged last year, with Genentech accusing JHL of stealing its confidential and proprietary information in order to guide the development of biosimilar versions of Rituxan (rituximab), Herceptin ... JHL has been developing biosimilars of

Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO

Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO its ‘big three’ antibiotic products – Rituxan, Herceptin and Avastin – which accounted for more than a third of sales last year.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...

Infographics